|
|||||
|
|
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions |
|
| Authors: | C. Prakash,A. Kamel,D. Cui,R. D. Whalen,J. J. Miceli,& D. Tweedie |
| Affiliation: | Departments of Drug Metabolism and;Clinical Research, Pfizer Central Research, Groton, CT 06340, USA |
| Abstract: | |
| Keywords: | cytochrome P450 drug interactions enzyme kinetics human liver microsomes ziprasidone |